Close Menu

NEW YORK (GenomeWeb) – Sera Prognostics plans this year to launch its PreTRM proteomic test for assessing pregnant women's risk of preterm delivery, company Chairman and CEO Gregory Critchfield told GenomeWeb this week.

The firm is currently in the process of validating the test in a 5,500-patient cohort collected through its Proteomic Assessment of Preterm Risk clinical study and expects results of the study to be available in the second quarter of 2015 with commercial launch of the test following around mid-year, Critchfield said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.

Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.

Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.

In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.